Suppressing the IGF1R–MTOR pathway has been found to mitigate their toxicity to motor neurons, highlighting its potential as a therapeutic target in SOD1‐associated ALS [121]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.